Oncology Medical News about tumor-reactive antibodies

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer
Gynecologic Oncology, 09/01/09

Taylor DD et al. – The quantitation of circulating tumor–reactive IgG can be used to identify the presence of ovarian cancer. The analyses of IgG recognition of specific exosomal antigens allows for the differentiation of women with benign ovarian masses from ovarian cancer, as well as distinguishing early and late stage ovarian cancers. Thus, the quantitative assessment of IgG reactive with specific tumor–derived exosomal proteins can be used as diagnostic markers for ovarian cancer.

<< Previous
p16INK4A in routine practice as a marker of cervical epithelial...

Next >>
Primary follicular lymphoma of the extrahepatic bile duct...

Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study
Arthritis Research & Therapy, 10/16/09 Relevance Score: 47%

Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay
Rheumatology, 10/08/09 Relevance Score: 47%

Anti-cyclic citrullinated peptide antibodies as a discriminating marker between rheumatoid arthritis and chronic hepatitis C-related polyarthropathy
Rheumatology International, 11/05/09 Relevance Score: 46%

Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient
Autoimmunity, 11/17/09 Relevance Score: 45%

HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis
Annals of Rheumatic Diseases, 11/13/09 Relevance Score: 45%